Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 5 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2391.23 | 226 / 226 | 100% | 35.36 | 406 / 406 |
pancreas | 100% | 1527.96 | 328 / 328 | 100% | 32.59 | 178 / 178 |
stomach | 100% | 2065.40 | 359 / 359 | 100% | 23.64 | 286 / 286 |
thymus | 100% | 5310.79 | 653 / 653 | 100% | 58.86 | 605 / 605 |
skin | 100% | 2268.24 | 1809 / 1809 | 100% | 24.30 | 471 / 472 |
uterus | 100% | 2752.29 | 170 / 170 | 100% | 31.13 | 458 / 459 |
brain | 100% | 2276.98 | 2636 / 2642 | 100% | 27.74 | 705 / 705 |
ovary | 100% | 2404.74 | 180 / 180 | 100% | 20.18 | 429 / 430 |
lung | 100% | 2686.77 | 578 / 578 | 100% | 21.99 | 1151 / 1155 |
intestine | 100% | 2876.23 | 966 / 966 | 100% | 29.38 | 525 / 527 |
adrenal gland | 100% | 1889.20 | 258 / 258 | 100% | 26.40 | 229 / 230 |
kidney | 100% | 2953.54 | 89 / 89 | 100% | 30.25 | 897 / 901 |
esophagus | 100% | 2549.66 | 1445 / 1445 | 99% | 15.07 | 182 / 183 |
bladder | 100% | 2447.86 | 21 / 21 | 99% | 26.59 | 501 / 504 |
prostate | 100% | 2777.73 | 245 / 245 | 99% | 27.57 | 499 / 502 |
breast | 100% | 2286.82 | 459 / 459 | 99% | 23.01 | 1109 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 26.58 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.45 | 29 / 29 |
spleen | 100% | 3855.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.55 | 1 / 1 |
blood vessel | 100% | 2809.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2080.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 2892.68 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1191.66 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 1261.02 | 781 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045047 | Biological process | protein targeting to ER |
GO_0006616 | Biological process | SRP-dependent cotranslational protein targeting to membrane, translocation |
GO_0043567 | Biological process | regulation of insulin-like growth factor receptor signaling pathway |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000502 | Cellular component | proteasome complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0036435 | Molecular function | K48-linked polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | ZFAND2B |
Protein name | AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Zinc finger, AN1-type domain 2B, isoform CRA_c (cDNA FLJ90090 fis, clone HEMBA1005430, highly similar to AN1-type zinc finger protein 2B) Zinc finger AN1-type containing 2B (cDNA FLJ60439, highly similar to AN1-type zinc finger protein 2B) Zinc finger AN1-type containing 2B |
Synonyms | AIRAPL hCG_1780765 |
Description | FUNCTION: Plays a role in protein homeostasis by regulating both the translocation and the ubiquitin-mediated proteasomal degradation of nascent proteins at the endoplasmic reticulum. It is involved in the regulation of signal-mediated translocation of proteins into the endoplasmic reticulum. It also plays a role in the ubiquitin-mediated proteasomal degradation of proteins for which signal-mediated translocation to the endoplasmic reticulum has failed. May therefore function in the endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (By similarity). By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway . . |
Accessions | Q8WV99 ENST00000409206.5 [Q8WV99-2] ENST00000409217.5 ENST00000409097.5 C9J1R6 H7C491 E9PFU9 ENST00000444522.6 [Q8WV99-1] ENST00000409594.5 [Q8WV99-2] ENST00000422255.5 ENST00000409336.5 [Q8WV99-1] ENST00000621130.4 ENST00000409412.5 ENST00000289528.10 [Q8WV99-1] B4DEN4 ENST00000448496.5 ENST00000436556.5 ENST00000409319.5 F8WEE4 ENST00000425849.1 B8ZZ56 B3KQB0 E7EV05 A0A087X0D9 |